Replimune, Inc.

Replimune, Inc. is a clinical-stage biotech company focused on developing innovative oncolytic immunotherapies to activate systemic anti-tumor immune responses, aiming to revolutionize cancer treatment and improve patient outcomes across various solid tumors.